PERIPHERAL BLOOD LYMPHOCYTES PHENOTYPIC COMPOSITION IN PATIENTS WITH CERVICAL PAPILOMAVIRUS INFECTIONS, WHICH IgG ANTIBODY TO HERPES SIMPLE VIRUSES WERE DETERMINED
DOI:
https://doi.org/10.11603/1681-2727.2018.2.9033Keywords:
papillomaviruses, herpesviruses, cervix, lymphocytes, natural killer, peripheral blood.Abstract
The aim of the work – to determine the phenotypic composition of peripheral blood lymphocytes in patients with cervical papillomavirus infection (PVI), whose blood serum showed IgG antibodies to herpes simplex viruses with (HSV)-I and/or (HSV)-2.
Materials and methods. 43 women (average age 26.5 years old) with human papillomavirus (HPV)-induced cervical papillomavirus infection diseases diagnosed by molecular-biological, colposcop, and cytological methods of examination were inspected. Serum screening for anti-HSV-1 and anti-HSV-2 IgG as well as examination of anti-HSV-2 IgG avidity index were examined by solid-phase enzyme-linked immunosorbent assay. The phenotypic composition of peripheral blood lymphocytes were examined by the flow cytofluorometry method using monoclonal antibodies (Beckman Coulter, USA) to CD3+, CD4+, CD8+, CD3+/HLA-DR+, CD3+/CD16+/€D56+, CD4+45RA+ CD16+/CD56+/CD8+ and CD16+/CD56+ antigens. The count of cells and data analysis were performed by cytofluormeter FC-500 (Beckman Coulter, США). The count of cells and analysis of the results were performed by cytofluormeter i. IgG antibodies to HSV-1, HSV-2 or to these two viruses in serum of patients with cervical PVI were detected in 90.0 % of cases, in which the clinical symptoms of herpetic infection were no identificated. IgG antibodies to HSV-2 in serum of patients had only mean or low avidity. In patients with IgG antibodies to HSV-2 or simultaneously with HSV-2 and HSV-1, and, above all, with low- avidity IgG antibodies to HSV-2 the frequency of HPV-induced cervical intraepithelial neoplasia (CIN) of І-ІІ and ІІІ grade and cancer in situ was increased. The number of CD3+, CD4+, CD8+, CD4+45RA+ аnd CD16+/CD56+ cells in the patients’ peripheral blood, as well as the CD4+/CD8+ index were not altered compared to the indicators for clinically healthy subjects (control). But the tendency to increase the number of CD16+/CD56+/CD8+ cells, as well as a significant increase in the number of СD3+/HLA-DR+ cells were determined. The number of CD3+/CD16+/CD56+ cells was reduced in peripheral blood of patients with low-avidity of IgG antibodies to HSV-2, whereas in the remaining patients it was at the control level. meter FC-500 (Beckman Coulter, USA).
Results and discussion. In patients serum with CU HPVI without clinical signs of herpetic infection to HSV-1, HSV-2 IgG antibodies, both these two viruses simultaneously were diagnosed in 90.0 % of cases. Anti-HSV-2 IgG in patients’ serum had only medium or low avidity. The frequency of revealing HPV-induced cervical intraepithelial neoplasia (CIN) I-ІІ and ІІІ degree of activity, and cancer in situ increased in patients with anti-HSV-2 IgG or simultaneously to anti-HSV-1 and anti-HSV-2 but, first of all, in patients with low avidity anti-HSV-2 IgG. The number of CD3+, CD4+, CD8+, CD4+45RA+ and CD16+/CD56+ cells in the patients’ peripheral blood, as well as CD4+/CD8+ index did not change as compared with group of clinically healthy persons (control group). However, there was determined the tendency of CD16+/CD56+/CD8+ cells number increase and significant СD3+/HLA-DR+ cells number increase. CD3+/CD16+/CD56+ cells number in peripheral patients’ blood with low avidity to anti-HSV-2 IgG antibodies was reduced whereas it was equal to control level in the rest patients.
Conclusion. In patients with CU HPVI without clinical manifestation of herpetic infection anti-HSV-2 low avidity IgG were identified. The frequency of more severe CIN cause was increased. There were more significant displacement of cell immunity confirmed by CD3+/HLA-DR+ cells number increase and tendency of CD16+/56+CD8+ cells number increase, too, on the background of СD3+/CD16+/CD56+ cytotoxic T-lymphocytes decrease. Complex individual treatment of these patients with anti-herpetic drugs must probably be used.
References
Christensen, N.D. (2016). HPV disease transmission protection and control. Microbial Cell, 3(9), 476-490. doi: 10.15698/mic2016.09.530.
Hus, I., Gonet-Sebastianka, J., Surdacka, A., Bojarska-Junak, A., Roliński, J. (2015). Analysis of peripheral blood immune cells after prophylactic immunization with HPV-16/18 ASO4-adjuvanted vaccine. Postepy Hig. Med. Dosw. (Online), 28(69), 543-548. doi: 10.5604/17322693.1150785.
Shanmugasundaram, S., & You, J. (2017). Targeting persistent human papillomavirus infection. Viruses, 9 (8), pii: E229. doi: 10.3390/v9080229.
Lazarenko, L.M., Nikitina, O.E., Nikitin, E,V., Demchenko, O.M., Kovtonyuk, G.V., Ganova, … & M.Ya. (2014). Development of biomarker panel to predict, prevent and create treatments tailored to the persons with human papillomavirus-induced cervical precancerous lesions. The EPMA J., 5(1), 1. doi:10.1186/1878-5085-5-1PMCID: PMC3901026
Graham, S.V. (2017). Keratinocyte Differentiation-Dependent Human Papillomavirus Gene Regulation. Viruses, 9 (245). pii: E245. doi: 10.3390/v9090245.
Deligeoroglou, E., Giannouli, A., Athanasopoulos, N., Karountzos, V., Vatopoulou, A., Dimopoulos, K., & Creatsas, G. (2013). HPV infection: immunological aspects and their utility in future therapy. Infectious Diseases in Obstetrics and Gynecology, (9), 540850. doi: 10.1155/2013/540850.
Cladel, N.M., Bertotto, A., Christensen, N.D. (2010). Human alpha and beta papillomaviruses use different synonymous codon profiles. Virus Genes, 40(3), 329-340. doi: 10.1007/s11262-010-0451-1.
Song, D., Li, H., Li, H., Dai J. (2015). Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer. Oncology Letters, 10 (2), 600-606. doi:10.3892/ol.2015.3295.
Guidry, J.T., Scott, R.S. (2017). The interaction between human papillomavirus and other viruses. Virus Research, 231, 139-147. doi: 10.1016/j.virusres.2016.11.002.
Frazer, I.H. (2009). Interaction of human papillomaviruses with the host immune system: a well evolved relationship. Virology, 384, 410-414. doi: 10.1016/j.virol.2008.10.004.
Colmenares, V., Noyola, D.E., Monsiváis-Urenda, A., Salgado-Bustamante, M., Estrada-Capetillo, L., González-Amaro, R., & Baranda, L. (2009). The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity. Infectious Agents and Cancer, 4 (11), 1005-11. doi: 10.1128/CVI.00043-12.
Senba, M., Mori, N. (2012). Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection. Oncology Rev., 6, e17. doi: 10.4081/oncol.2012.e17.
Skeate, J.G., Porras, T.B., Woodham, A.W., Jang, J.K., Taylor, J.R., Brand, H.E., … & Kast, W.M. (2012). Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infection. Clinical and Vaccine Immunology, 19 (7), 1005-1011. doi: 10.1128/CVI.00043-12.
Jaishankar, D., Shukla, D. (2016). Genital Herpes: Insights into Sexually Transmitted Infectious Disease. Microbial Cell, 3(9), 438-450. doi: 10.15698/mic2016.09.528.
Bedoui, S., Heath, W.R., & Mueller, S.N. (2016). CD4(+) T-cell help amplifies innate signals for primary CD8(+) T-cell immunity. Immunological Rev., 272, 1, 52-64. doi: 10.1111/imr.12426.
Sauerbrei, A. (2016). Herpes genitalis: Diagnosis, treatment and prevention. Geburtshilfe Frauenheilkd, 76 (12), 1310-1317. doi: 10.1055/s-0042-116494.
Da Silva, D.M., Woodham, A.W., Skeate, J.G., Rijkee, L.K., Taylor, J.R., Brand, H.E., … & Kast, W.M. (2015). Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C. Clinical Immunology, 161 (2), 197-208. doi: 10.1016/j.clim.2015.09.003.
Handisurya, A., Day, P.M., Thompson, C.D., Bonelli, M., Lowy, D.R., Schiller, J.T. (2014). Strain-specific properties and T cells regulate the susceptibility to papilloma induction by Mus musculus papillomavirus 1. PLoS Pathogens, 10 (8), e1004314. doi: 10.1371/journal.ppat.1004314.
Pita-Lopez, M.L., Ortiz-Lazareno, P.C., Navarro-Meza, M., Santoyo-Telles, F., Peralta-Zaragoza, O. (2014). CD28-, CD45RA(null/dim) and natural killer-like CD8+ T cells are increased in peripheral blood of women with low-grade cervical lesions. Cancer Cell International, 14 (1), 97. doi: 10.1186/s12935-014-0097-5.
Visser, J., Nijman, H.W., Hoogenboom, B.N., Jager, P., van Baarle, D., Schuuring, E., … & Daemen, T. (2007). Frequencies and role of regulatory T cells in patients with (pre)malignant cervical neoplasia. Clinical & Experimental Immunology, 150 (2), 199-209. doi:10.1111/j.1365-2249.2007.03468.x.
Pievani, A., Borleri, G., Pende, D., Moretta, L., Rambaldi, A., Golay J., … & Introna M. (2011). Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity. Blood, 118(12), 3301-3310. doi: 10.1182/blood-2011-02-336321.
Colmenares, V., Noyola, D.E., Monsiváis-Urenda, A., Salgado-Bustamante, M., Estrada-Capetillo L., González-Amaro, R., & Baranda, L. (2012). Human papillomavirus immunization is associated with increased expression of different innate immune regulatory receptors. Clinical and Vaccine Immunology, 19 (7), 1005-1011. doi: 10.1128/CVI.00043-12.
Downloads
Published
How to Cite
Issue
Section
License
Journal Infectious Disease (Infektsiini Khvoroby) allows the author(s) to hold the copyright without registration
Users can use, reuse and build upon the material published in the journal but only for non-commercial purposes
This journal is available through Creative Commons (CC) License BY-NC "Attribution-NonCommercial" 4.0